FG2216

HIF-prolyl hydroxylase inhibitor CAS# 223387-75-5

FG2216

Catalog No. BCC6402----Order now to get a substantial discount!

Product Name & Size Price Stock
FG2216: 5mg $138 In Stock
FG2216: 10mg Please Inquire In Stock
FG2216: 20mg Please Inquire Please Inquire
FG2216: 50mg Please Inquire Please Inquire
FG2216: 100mg Please Inquire Please Inquire
FG2216: 200mg Please Inquire Please Inquire
FG2216: 500mg Please Inquire Please Inquire
FG2216: 1000mg Please Inquire Please Inquire
Related Products
  • BAY 87-2243

    Catalog No.:BCC4131
    CAS No.:1227158-85-1
  • PX 12

    Catalog No.:BCC2436
    CAS No.:141400-58-0
  • DMOG

    Catalog No.:BCC2433
    CAS No.:89464-63-1
  • KC7F2

    Catalog No.:BCC2434
    CAS No.:927822-86-4
  • IOX2(Glycine)

    Catalog No.:BCC2229
    CAS No.:931398-72-0

Quality Control of FG2216

Number of papers citing our products

Chemical structure

FG2216

3D structure

Chemical Properties of FG2216

Cas No. 223387-75-5 SDF Download SDF
PubChem ID 6914666 Appearance Powder
Formula C12H9ClN2O4 M.Wt 280.66
Type of Compound N/A Storage Desiccate at -20°C
Synonyms YM-311
Solubility DMSO : ≥ 31 mg/mL (110.45 mM)
*"≥" means soluble, but saturation unknown.
Chemical Name 2-[(1-chloro-4-hydroxyisoquinoline-3-carbonyl)amino]acetic acid
SMILES C1=CC=C2C(=C1)C(=C(N=C2Cl)C(=O)NCC(=O)O)O
Standard InChIKey OUQVKRKGTAUJQA-UHFFFAOYSA-N
Standard InChI InChI=1S/C12H9ClN2O4/c13-11-7-4-2-1-3-6(7)10(18)9(15-11)12(19)14-5-8(16)17/h1-4,18H,5H2,(H,14,19)(H,16,17)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of FG2216

DescriptionFG-2216 is a potent HIF-prolyl hydroxylase inhibitor with IC50 of 3.9 uM for PDH2 enzyme; orally bioavailable and induced significant and reversible Epo induction in vivo. IC50 value: 3.9 uM [1] Target: PDH inhibitor FG-2216 was orally bioavailable and induced significant and reversible Epo induction in vivo (82- to 309-fold at 60 mg/kg). Chronic oral dosing in male rhesus macaques was well tolerated, significantly increased erythropoiesis, and prevented anemia induced by weekly phlebotomy. Furthermore, modest increases in HbF-containing red cells and reticulocytes were demonstrated by flow cytometry, though significant increases in HbF were not demonstrated by high-pressure liquid chromatography (HPLC) [2].

References:
[1]. Hong YR, et al. [(4-Hydroxyl-benzo[4,5]thieno[3,2-c]pyridine-3-carbonyl)-amino]-acetic acid derivatives; HIF prolyl 4-hydroxylase inhibitors as oral erythropoietin secretagogues. Bioorg Med Chem Lett. 2013 Nov 1;23(21):5953-7. [2]. Hsieh MM, et al. HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques. Blood. 2007 Sep 15;110(6):2140-7.

FG2216 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

FG2216 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of FG2216

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.563 mL 17.8152 mL 35.6303 mL 71.2606 mL 89.0758 mL
5 mM 0.7126 mL 3.563 mL 7.1261 mL 14.2521 mL 17.8152 mL
10 mM 0.3563 mL 1.7815 mL 3.563 mL 7.1261 mL 8.9076 mL
50 mM 0.0713 mL 0.3563 mL 0.7126 mL 1.4252 mL 1.7815 mL
100 mM 0.0356 mL 0.1782 mL 0.3563 mL 0.7126 mL 0.8908 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on FG2216

FG-2216 is a potent HIF-prolyl hydroxylase inhibitor. IC50 = 3.9 μM for PDH2 enzyme.

HIFs (hypoxia inducible factors) are transcription factor that activated by low oxygen availability. It leads to cellular, tissue and organismal adaptive response to hypoxia. Increased hemoglobin

levels are associated with intrauterine hypoxia. In cooperation with other transcriptional coactivators, HIF induces transcription of genes that ameliorate the effects of hypoxia, including erythropoietin and its receptor.

In rhesus macaques, FG-2216 reversibly activates endogenous erythropoietin (82- to 309-fold at 60 mg/kg), and as early as 4 hours after oral administration of FG-2216, circulating plasma Epo levels increases. [1]

Chronic administration of FG-2216 is well tolerated and induces erythropoiesis in rhesus macaques. It also induced a small elevation of hemoglobin expression in vivo. FG-2216–treated animals exerts rise in the percentage of hemoglobin-containing reticulocytes (% F+ retics) 1 to 2 weeks after chronic dosing began. [1]

Reference:
1.  Hsieh MM, Linde NS, Wynter A et al. HIF prolyl hydroxylase inhibition
results in endogenous erythropoietin induction, erythrocytosis, and modest fetal
hemoglobin expression in rhesus macaques.  Blood. 2007 Sep 15;110(6):2140-7.

Featured Products
New Products
 

Description

FG-2216 (IOX3; YM311) is a potent HIF-prolyl hydroxylase inhibitor with IC50 of 3.9 uM for PDH2 enzyme; orally bioavailable and induced significant and reversible Epo induction in vivo.

Keywords:

FG2216,223387-75-5,YM-311,Natural Products,HIF, buy FG2216 , FG2216 supplier , purchase FG2216 , FG2216 cost , FG2216 manufacturer , order FG2216 , high purity FG2216

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: